7 results
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Patients With CKD ... patients with T2D, CKD ... and CKD should ... evidence-based pharmacologic ... #Diabetes #CKD #
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Dissection • CKD ... , DM, ESRD, PKD ... #Medications #Hypertension ... Comorbidities #pharmacology
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... contraindicated in CKD ... Sulfonylureas #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
(stage IV or V CKD ... Add sliding scale ... Weight #Based #pharmacology ... endocrinology #diabetes ... #DM2
Causes of Chronic Kidney Disease - Differential Diagnosis Algorithm
Decreased kidney function (eGFR < 60 ml/min/1.73 m2)
60 ml/min/1.73 m2 ... Proteinuria) • Diabetes ... • Hypertension ... Hyperphosphatemia #CKD
Algorithm for Diagnosis and Management of Resistant Hypertension in CKD
Pseudoresistant Hypertension - Reduce barriers to adherence:
in CKD Pseudoresistant ... Evaluate for CKD ... 30 mL/min/1.73 m2 ... Add loop diuretic ... #CKD #Algorithm
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
cardiomyopathy, hypertension ... factors (smoking, hypertension ... , diabetes, dyslipidemia ... Lapatinib, Pertuzumab, Ado-trastuzumab ... cardiology #oncology #pharmacology